Actively Recruiting
Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery
Led by Benha University · Updated on 2026-03-11
300
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cesarean section (CS) is one of the most frequently performed surgical procedures globally, with an increasing demand for safe and effective anesthesia techniques. Regional anesthesia, particularly intrathecal anesthesia, has become the method of choice for elective cesarean deliveries.The most commonly used local anesthetic for intrathecal anesthesia is bupivacaine.Recent studies have focused on adjunctive agents to enhance the efficacy of local anesthetics.
CONDITIONS
Official Title
Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Full-term pregnant women undergoing elective cesarean section under spinal anesthesia
- Age between 20 and 35 years
- ASA physical status II to III
You will not qualify if you...
- Multiple pregnancies
- Cardiovascular disease such as pre-eclampsia and hypertension
- Serious hepatic dysfunction (Child-Pugh class C)
- Serious renal dysfunction requiring dialysis before surgery
- History of alcohol or opioid addiction
- Contraindication to spinal anesthesia
- Refusal to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Banha Faculity of Medicine
Banhā, Elqalyoubea,, Egypt, 13511
Actively Recruiting
Research Team
F
fatma ahmed abdelfatah, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here